No recent analyst price targets found for BPMUF.
Latest News for BPMUF
Basilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, May 28, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for BPMUF.
Senate Trading
No Senate trades found for BPMUF.
U.S. House Trading
No House trades found for BPMUF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.